↓ Skip to main content
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

news
1 news outlet
reddit
1 Redditor

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
OP0164 BLISS-LN: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS
Published in
Annals of the Rheumatic Diseases, June 2020
DOI 10.1136/annrheumdis-2020-eular.3881
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 4 24%
Researcher 3 18%
Student > Doctoral Student 1 6%
Student > Ph. D. Student 1 6%
Student > Postgraduate 1 6%
Other 0 0%
Unknown 7 41%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 7 41%
Immunology and Microbiology 1 6%
Decision Sciences 1 6%
Materials Science 1 6%
Unknown 7 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2021.
All research outputs
#9,817,684
of 32,838,942 outputs
Outputs from Annals of the Rheumatic Diseases
#5,130
of 10,229 outputs
Outputs of similar age
#162,798
of 451,761 outputs
Outputs of similar age from Annals of the Rheumatic Diseases
#161
of 338 outputs
Altmetric has tracked 32,838,942 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 10,229 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.4. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,761 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 338 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.